Related Experiment Videos
Protein kinase C and transmitter release
H Majewski1, P Kotsonis, L Iannazzo
1Prince Henry's Institute of Medical Research, Clayton, Victoria, Australia. harry.majewski@med.monash.edu.au
Clinical and Experimental Pharmacology & Physiology
|August 1, 1997
Summary
Protein kinase C (PKC) activation enhances noradrenaline release in nerves. This enzyme plays a key role in neurotransmitter release, with potential therapeutic applications.
Area of Science:
- Neuroscience
- Cellular Biology
- Pharmacology
Background:
- Protein kinase C (PKC) is a crucial enzyme activated by second messengers.
- PKC is involved in regulating neurotransmitter release in noradrenergic nerves.
- Its activation is linked to diacylglycerol (DAG) production and subsequent protein phosphorylation.
Purpose of the Study:
- To investigate the role of PKC in noradrenaline release from different types of neurons.
- To explore the mechanisms underlying PKC-mediated facilitation of transmitter release.
- To assess the potential therapeutic implications of modulating PKC activity.
Main Methods:
- Studied PKC activity and its effect on noradrenaline release in central and sympathetic neurons.
- Utilized PKC inhibitors and phorbol esters to modulate enzyme activity.
- Examined the influence of stimulation frequency and intracellular calcium levels.
Main Results:
- PKC is tonically active in central noradrenergic neurons, facilitating noradrenaline release.
- In sympathetic nerves, PKC inhibition affects release primarily during high-frequency stimulation.
- Phorbol ester activation of PKC significantly enhances action potential-evoked noradrenaline release.
Conclusions:
- PKC activation is a potent mechanism for enhancing noradrenaline release.
- Differences exist in PKC's role between central and sympathetic noradrenergic neurons.
- Modulating PKC activity holds promise for therapeutic interventions in neurological disorders.